Clinical, pathological and prognostic implications of USP22, SIRT1 and E-cadherin expression in papillary thyroid cancer (PTC) and adjacent non-neoplastic tissue

Table 2 USP22, SIRT1 and E-cadherin expression in all the studied samples (No 80)

	PTC N = 40	Adjacent non-neoplastic Thyroid tissue N = 40		Total N = 80			P
	No.	%	No.	%	No.	%	P
USP 22
Low	15	37.5%	36	90.0%	51	63.8%	< 0.001
High	25	62.5%	4	10.0%	29	36.3%	< 0.001
SIRT1
Low	21	52.5%	32	80.0%	53	66.3%	0.009
High	19	47.5%	8	20.0%	27	33.8%	0.009
E-cadherin
Low	25	62.5%	11	27.5%	36	45.0%	0.002
High	15	37.5%	29	72.5%	44	55.0%	0.002

ISSN: 2520-8454